Ryan AM, Healy LA, Power DG, et al. Short-term nutritional implications of total gastrectomy for malignancy, and the impact of parenteral nutritional support[J]. Clin Nutr, 2007, 26(6): 718-727.
Kern KA, Norton JA. Cancer cachexia[J]. JPEN J Parenter Enteral Nutr, 1998, 12(3): 286-298.
[5]
Green SM, Watson R. Nutritional screening and assessment tools for use by nurses: literature review[J]. J Adv Nurs, 2005, 50(1): 69-83.
[6]
Buzby GP, Mullen JL, Matthews DC, et al. Prognostic nutritional index in gastrointestinal surgery[J]. Am J Surg, 1980, 139(1): 160-167.
[7]
Guigoz Y, Vellas BJ, Garry PJ. Mini nutritional assessment: a practical assessment tool for grading the nutritional state of elderly patients[J]. Facts Res Gerontonol, 1994, 4(Suppl 2): 15-59.
[8]
Kondrup J, Rasmussen HH, Hamberg O, et al. Nutritional risk screening (NRS 2002): a new method based on an analysis of controlled clinical trials[J]. Clin Nutr, 2003, 22(3): 321-336.
Veterans Affairs Total Parenteral Nutrition Co-operative Study Group. Perioperative total parenteral nutrition in surgical patients[J]. N Engl J Med, 1991, 325(Suppl 2): 525-532.
[11]
Braga M, Ljungqvist O, Soeters P, et al. ESPEN guidelines on parenteral nutrition: surgery[J]. Clin Nutr, 2009, 28(4): 378-386.
[12]
Bozzetti F, Gavazzi C, Cozzaglio L, et al. Total parenteral nutrition and tumor growth in malnourished patients with gastric cancer[J]. Tumori, 1999, 85(3): 163-166.
[13]
Al Samaraee A, McCallum IJ, Coyne PE, et al. Nutritional strategies in severe acute pancreatitis: a systematic review of the evidence[J]. Surgeon, 2010, 8(2): 105-110.
[14]
Klek S. Immunonutrition in cancer patients[J]. Nutrition, 2011, 27(2): 144-145.
[15]
Oh DY, Talukdar S, Bae EJ, et al. GPR120 is an omega-3 fatty acid receptor mediating potent anti-inflammatory and insulin-sensitizing effects[J]. Cell, 2010, 142(5): 687-698.
[16]
Mudge L, Isenring E, Jamieson GG. Immunonutrition in patients undergoing esophageal cancer resection[J]. Dis Esophagus, 2011, 24(3): 160-165.
[17]
Wise DR, Thompson CB. Glutamine addiction: a new therapeutic target in cancer[J]. Trends Biochem Sci, 2010, 35(8): 427-433.
[18]
Parkin DM, Ferlay J, Curado MP, et al. Fifty years of cancer incidence: CI5I-IX[J]. Int J Cancer, 2010, 127(12): 2918-2927.
[19]
Brenner H, Rothenbacher D, Arndt V. Epidemiology of stomach cancer[J]. Methods Mol Biol, 2009, 472(2): 467-477.
[20]
Wie GA, Cho YA, Kim SY, et al. Prevalence and risk factors of malnutrition among cancer patients according to tumor location and stage in the National Cancer Center in Korea[J]. Nutrition, 2010, 26(3): 263-268.
